Investor directory

Novartis

Novartis is a global healthcare company based in Switzerland, providing innovative medicines and solutions to address evolving patient needs worldwide. With over 100,000 employees across 140 countries, they focus on discovering new treatments in areas such as oncology, immunology, neuroscience, and cardiovascular diseases.
https://www.novartis.com/
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=98398
https://www.privateequityinternational.com/database/#/profile?id=2788

Elena Battistello

Analyst

Laura Brass

Managing Director

Adam Cotton

Associate

Bart Dzikowski

Managing Director

Mathias Frederiksen

Principal

Sharon Kiernan

Director of Strategic Planning and Business Operations, Office of Chief Technology Transformation Officer

Anja Konig

Managing Director

Michelle Ma

Analyst

Nadene McIntyre

Associate Director Access and Reimbursement

Campbell Murray MD

Managing Director

Marion Mutter

Senior Clinical Research Associate

Florian Müllershausen

Managing Director

Aaron Nelson

Managing Director

Pascal Qian

Executive Director ( Head of Solid Tumor)

Michal Silverberg

Managing Director

Lauren Silverman

Managing Director

Beat Steffen

Managing Director

Marianne Uteng

Managing Director

Alberto Villena

Director, M&A, Finance

Maurizio Voi

Vice President, Global Program Head, Tislelizumab, Immuno Oncology

Steve Weinstein

Managing Director

Past deals in Macau

SanReno Therapeutics

Acquisition in 2024
SanReno Therapeutics is a biotechnology company that specializes in the development, manufacturing, and commercialization of therapies for kidney diseases and related conditions. Operating primarily in the People’s Republic of China, Hong Kong, Macau, Taiwan, and Singapore, the company is dedicated to advancing research and development in this therapeutic area. Formed as a joint venture between Chinook Therapeutics, Frazier Healthcare Partners, and Pivotal bioVenture Partners China, SanReno Therapeutics aims to create innovative solutions that enhance the quality of life for patients suffering from kidney-related ailments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.